Clinical Trials Browser

Not yet recruiting × Biliary Tract Neoplasms × S 1 (combination) × Clear all

NCT06903273 2025-03-30

TisGCS for BTC

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT06662877 2024-10-29

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

Phase 2/3 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms